Lactylation in Cancer: Unlocking the Key to Drug Resistance and Therapeutic Breakthroughs
Oncology Research · 2025
DOI: 10.32604/or.2025.067343 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Research, 2025. Verfasst von Xiangnan Feng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical School of Medicine, Anhui Medical University, Hefei, 230022, China. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Neoplasms, Protein Processing, Post-Translational, Lactic Acid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical School of Medicine, Anhui Medical University, Hefei, 230022, China.
- Department of Gastrointestinal Surgery, The Second People's Hospital of Wuhu, Wuhu, 241000, China.
Zitieren
APA
Feng, X., Li, D., Wang, P., Li, X., & Li, G. (2025). Lactylation in Cancer: Unlocking the Key to Drug Resistance and Therapeutic Breakthroughs. Oncology Research. https://doi.org/10.32604/or.2025.067343
Vancouver
Feng X, Li D, Wang P, Li X, Li G. Lactylation in Cancer: Unlocking the Key to Drug Resistance and Therapeutic Breakthroughs. Oncology Research. 2025. doi:10.32604/or.2025.067343
BibTeX
@article{Feng2025,
author = {Feng, Xiangnan and Li, Dayong and Wang, Pingyu and Li, Xinyu and Li, Guangyao},
title = {Lactylation in Cancer: Unlocking the Key to Drug Resistance and Therapeutic Breakthroughs},
journal = {Oncology Research},
year = {2025},
doi = {10.32604/or.2025.067343}
}
EUVIMED